Learn more about Biophysical characterization with the Creoptix WAVEsystem

Event-Datum: 07.09.2022

Time: 13:45 – 16:45 CET

Location: DiNAQOR AG, Wagistrasse 25, 8952 Schlieren

Pushing the Boundaries in Biomolecular Interaction Analysis with the Creoptix WAVEsystem and waveRAPID – From Biologics to Fragment-Based Drug Discovery.

We’re visiting six locations across the EU and the US to deliver the latest insights into binding kinetics and affinity – from fragment-based to biologics drug discovery.


  • Edward A. FitzGerald – Application Scientist
  • Michael Hennig – CEO of leadXpro

More information and registration